YIH
SRGA

Y-Intercept (HK)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Y-Intercept (HK)’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-756
Closed -$32K – 998
2021
Q2 		$32K Buy
+756
New +$38.7K 0.01% 574

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Y-Intercept (HK)'s SRGA Position: Q3 2021 in Review

Y-Intercept (HK) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2021, closing a stake of 756 shares — an estimated $32K sold.

Y-Intercept (HK) first reported a position in SRGA in Q2 2021 and held it in 1 quarter. The position peaked at $32K in Q2 2021. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2021.

  • Y-Intercept (HK) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Y-Intercept (HK) sold 756 Surgalign Holdings, Inc. Common Stock shares in Q3 2021, an estimated $32K.
  • Y-Intercept (HK) first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Y-Intercept (HK)'s Surgalign Holdings, Inc. Common Stock position peaked at $32K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2021.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.